Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

US-based ocular disorder treatment developer LumiThera reached the second close of its series C round on Monday having raised more than $10m from investors including optics technology producer and distribution partner Nikon Corporation. The round is being led by venture capital fund WaterStar Capital and follows a $5.5m series B featuring WaterStone Capital and RPR…

The rest of this content is only accessible to Global Corporate Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.